DEA decision keeps major restrictions in place on marijuana research
(By Andrew Joseph for ST A T) F ederal drug enforcement authorities announced Thursday that they would continue defining marijuana
Read More
Part D/Prescription Drugs
Nonprofit seeks to dispel ‘myths’ about how it assesses drug values
(By Ed Silverman for ST A T) I n the face of growing criticism over its efforts to place a
Read MoreUS babies born addicted to opioids has tripled in 15 years, CDC says
(By Casey Ross for ST A T) T he number of babies being born in the United States addicted to
Read MoreImprecise research threatens precision medicine
(By Spencer Phillips Hey and Aaron S. Kesselheim for ST A T) T he right treatment for the right patient
Read MoreIRS is urged to investigate Gilead for ‘dodging’ US taxes
(By Ed Silverman for ST A T) A n advocacy group is urging the US Internal Revenue Service and the
Read MoreInsurance Rules Can Hamper Recovery From Opioid Addiction
(By Jake Harper, Side Effects Public Media, for Kaiser Health News) Twice a day, Angela and Nate Turner of Greenwood,
Read MoreThe Future of Drug Pricing
Could global pressure on health spending force the pharmaceutical industry to embrace pricing drugs based on clinical outcomes instead of
Read MoreSeniors Can Lower Their Medicare Drug Costs
Do you know the seven strategies to consider that could help lower your Medicare prescription drug costs such as: stay
Read MoreThe race for a Zika vaccine is intense. But it may be missing the most important players
(By Helen Branswell for ST A T) About a year ago, before the Zika virus grabbed global attention, there were
Read MoreAbbVie and Amgen lock horns in the latest squabble over biosimilars
(By Ed Silverman for ST A T) I n the latest contest over biosimilars, AbbVie has filed a patent infringement
Read More